Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jun;43(6):756–766. doi: 10.1038/bjc.1981.113

Enhancement of the effect of cytotoxic drugs by radiosensitizers.

W M Martin, N J McNally, J De Ronde
PMCID: PMC2010716  PMID: 7248157

Abstract

Misonidazole (MISO) potentiates the action of cyclophosphamide (CY) and melphalan in the WHFIB culture-adapted fibrosarcoma, whether assayed by cell survival or tumour-growth delay. In the case of CY, MISO also inhibited recovery from potentially lethal drug damage. The optimum effect was seen when MISO was given 1 h before CY, though it was also effective when given 6 h before or 1 h after the drug. Other radiosensitizers also potentiated the action of CY. There was only a small effect of MISO on the LD50 of CY and no effect on CY toxicity as assayed by changes in blood counts or damage to bladder epithelium. However, mice bearing multiple lung tumours were less able to cope with the combined treatment than those bearing s.c. tumours.

Full text

PDF
756

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams G. E., Clarke E. D., Flockhart I. R., Jacobs R. S., Sehmi D. S., Stratford I. J., Wardman P., Watts M. E., Parrick J., Wallace R. G. Structure-activity relationships in the development of hypoxic cell radiosensitizers. I. Sensitization efficiency. Int J Radiat Biol Relat Stud Phys Chem Med. 1979 Feb;35(2):133–150. doi: 10.1080/09553007914550151. [DOI] [PubMed] [Google Scholar]
  2. Adams G. E., Flockhart I. R., Smithen C. E., Stratford I. J., Wardman P., Watts M. E. Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res. 1976 Jul;67(1):9–20. [PubMed] [Google Scholar]
  3. Anderson R. F., Patel K. B. Effect of lipophilicity of nitroimidazoles on radiosensitization of hypoxic bacterial cells in vitro. Br J Cancer. 1979 Jun;39(6):705–710. doi: 10.1038/bjc.1979.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brown J. M. Cytotoxic effects of the hypoxic cell radiosensitizer Ro 7-0582 to tumor cells in vivo. Radiat Res. 1977 Dec;72(3):469–486. [PubMed] [Google Scholar]
  5. Cox P. J. Cyclophosphamide cystitis--identification of acrolein as the causative agent. Biochem Pharmacol. 1979 Jul 1;28(13):2045–2049. doi: 10.1016/0006-2952(79)90222-3. [DOI] [PubMed] [Google Scholar]
  6. Denekamp J. Cytotoxicity and radiosensitization in mouse and man. Br J Radiol. 1978 Aug;51(608):636–637. doi: 10.1259/0007-1285-51-608-636. [DOI] [PubMed] [Google Scholar]
  7. Denekamp J., McNally N. J. The magnitude of hypoxic cell cytotoxicity of misonidazole in human tumours. Br J Radiol. 1978 Sep;51(609):747–748. doi: 10.1259/0007-1285-51-609-747. [DOI] [PubMed] [Google Scholar]
  8. Dische S., Fowler J. F., Saunders M. I., Stratford M. R., Anderson P., Minchinton A. I., Lee M. E. A drug for improved radiosensitization in radiotherapy. Br J Cancer. 1980 Jul;42(1):153–155. doi: 10.1038/bjc.1980.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro 07-0582: experience with multiple doses. Br J Cancer. 1977 May;35(5):567–579. doi: 10.1038/bjc.1977.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Flockhart I. R., Large P., Troup D., Malcolm S. L., Marten T. R. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole. Xenobiotica. 1978 Feb;8(2):97–105. doi: 10.3109/00498257809060388. [DOI] [PubMed] [Google Scholar]
  11. Flockhart I. R., Sheldon P. W., Stratford I. J., Watts M. E. A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties. Int J Radiat Biol Relat Stud Phys Chem Med. 1978 Jul;34(1):91–94. doi: 10.1080/09553007814550661. [DOI] [PubMed] [Google Scholar]
  12. George K. C., Hirst D. G., McNally N. J. Effect of hyperthermia on cytotoxicity of the radiosensitizer Ro-07-0582 in a solid mouse tumour. Br J Cancer. 1977 Mar;35(3):372–375. doi: 10.1038/bjc.1977.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hall E. J., Roizin-Towle L. Hypoxic sensitizers: radiobiological studies at the cellular level. Radiology. 1975 Nov;117(2):453–457. doi: 10.1148/117.2.453. [DOI] [PubMed] [Google Scholar]
  14. McNally N. J., Denekamp J., Sheldon P. W., Flockhart I. R. Hypoxic cell sensitization by misonidazole in vivo and in vitro. Br J Radiol. 1978 Apr;51(604):317–318. doi: 10.1259/0007-1285-51-604-317. [DOI] [PubMed] [Google Scholar]
  15. McNally N. J., Denekamp J., Sheldon P., Flockhart I. R., Stewart F. A. Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer. Radiat Res. 1978 Mar;73(3):568–580. [PubMed] [Google Scholar]
  16. Roizin-Towle L., Hall E. J. Studies with bleomycin and misonidazole on aerated and hypoxic cells. Br J Cancer. 1978 Feb;37(2):254–260. doi: 10.1038/bjc.1978.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Stewart F. A., Michael B. D., Denekamp J. Late radiation damage in the mouse bladder as measured by increased urination frequency. Radiat Res. 1978 Sep;75(3):649–659. [PubMed] [Google Scholar]
  18. Stratford I. J., Adams G. E., Horsman M. R., Kandaiya S., Rajaratnam S., Smith E., Williamson C. The interaction of misonidazole with radiation, chemotherapeutic agents, or heat: a preliminary report. Cancer Clin Trials. 1980 Fall;3(3):231–236. [PubMed] [Google Scholar]
  19. Sutherland R. M. Selective chemotherapy of noncycling cells in an in vitro tumor model. Cancer Res. 1974 Dec;34(12):3501–3503. [PubMed] [Google Scholar]
  20. Twentyman P. R. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide. Br J Cancer. 1977 Feb;35(2):208–217. doi: 10.1038/bjc.1977.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Urtasun R. C., Band P., Chapman J. D., Rabin H. R., Wilson A. F., Fryer C. G. Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology. 1977 Mar;122(3):801–804. doi: 10.1148/122.3.801. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES